IL-36 Psoriasis Biologic Selection Panel

A blood or skin-lesion test measuring IL-36α, IL-36β, and IL-36γ to classify psoriasis patients as 'IL-36-driven,' guiding selection between anti-IL-17, anti-IL-23, and anti-IL-36R biologic therapies.